Pharma's Almanac TV
PA TV
Dashboard
Your Name
Your Email
Manage Account
Sign Out
Sign In
Register
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Research
CDMO
CRO
Excipients
Pharmaceutical Equipment
Pharmaceutical Intermediates
Supply Chain Logistics
Magazine
Current Issue
Archive
Community
Company A to Z
Content Filter
More+
Staffing
Media Kit
By The Numbers
Clinical Trials
453 Articles Available
1
19
Can't find what you're looking for? Try our
advanced search
.
Clinical Trials
Sun Pharma Receives Approval from DCGI to Initiate Clinical Trial with Nafamostat in Covid-19 Patients
PR-M06-20-NI-004
COVID-19
Montefiore-Einstein Scientists Lead Two Trials of Leronlimab for COVID-19
PR-M05-20-NI-045
Oncology
AstraZeneca Collaborates with ArcherDX to Use Personalized Cancer Assays to Detect Minimal Residual Disease in Lung Cancer Trials
PR-M05-20-NI-044
Clinical Trials
Philips Launches HealthSuite Clinical Trial Accelerator
PR-M05-20-NI-034
COVID-19 Vaccine
Moderna Announces Positive Interim Phase 1 Data for its mRNA Vaccine (mRNA-1273) Against Novel Coronavirus
PR-M05-20-NI-027
Clinical Trials
MyoKardia Announces Primary and All Secondary Endpoints Met in Phase 3 Clinical Trial for the Treatment of Obstructive Hypertrophic Cardiomyopathy
PR-M05-20-NI-021
Clinical Trials
Yourway and Firma Clinical Research Collaborate to Administer Coordinated Supply Delivery for Home-Health Clinical Trial Visits
PR-M05-20-NI-016
COVID-19 Clinical Trials
Enlivex Announces Initiation of Multi-Center Phase II Investigator-Initiated Clinical Trial of Allocetra in COVID-19 Patients
PR-M05-20-NI-017
FDA Approval
Novartis Announces FDA Approval of MET Inhibitor Tabrecta™ for Metastatic Non-Small Cell Lung Cancer with METex14
PR-M05-20-NI-011
COVID-19
Vir and Alnylam Identify RNAi Therapeutic Development Candidate Targeting SARS-CoV-2
PR-M05-20-NI-008
COVID-19
Wyss-Designed Swabs Enter Human Trials for COVID-19
PR-M05-20-NI-003
Clinical Trials
Glenmark Receives Approval to Conduct Clinical Trials in India on Favipiravir Antiviral Tablets for COVID-19 Patients
PR-M04-20-NI-044
COVID-19 Clinical Trial
Sanofi and Regeneron Provide Update on U.S. Phase 2/3 Adaptive-Designed Trial in Hospitalized COVID-19 Patients
PR-M04-20-NI-040
COVID-19 Lung Injury
Theravance Biopharma Doses First Patients with Acute Lung Injury Caused by COVID-19
PR-M04-20-NI-035
COVID-19 Clinical Trials
Novartis to Sponsor Large Clinical Trial of Hydroxychloroquine in Hospitalized COVID-19 Patients
PR-M04-20-NI-029
Clinical Trials
Roivant Doses First Patient in Pivotal BREATHE Clinical Trial Evaluating Gimsilumab in COVID-19 Patients
PR-M04-20-NI-024
COVID-19 Clinical Testing
Lilly Begins Clinical Testing of Therapies for COVID-19
PR-M04-20-NI-018
Gilead Sciences Statement on Access to Remdesivir Outside of Clinical Trials
PR-M04-20-NI-003
Biohaven to Advance Vazegepant Into Phase 3 for Acute Migraine Treatment
PR-M03-20-NI-036
Vaccitech and Oxford University Announce Promising Phase 2a Data on Prostate Cancer Immunotherapy
PR-M03-20-NI-036
COVID-19
Roche Initiates Phase III Clinical Trial of Actemra/RoActemra in Patients with Severe COVID-19 Pneumonia
PR-M03-20-NI-030
Clinical Trials
FDA Urges Remote Clinical Trials
PR-M03-20-NI-029
Coronavirus
Gilead Sciences Initiates Two Phase 3 Studies of Investigational Antiviral Remdesivir for the Treatment of COVID-19
PR-M02-20-NI-037
Clinical Trials
Regulus Therapeutics Reinitiates Multiple Ascending Dose Study of RGLS4326 for the Treatment of ADPKD
PR-M02-20-NI-023
1
19
»
